Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(14%)
Terminated
1(14%)

Phase Distribution

Ph phase_3
1
14%
Ph not_applicable
6
86%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Terminated(1)
Other(5)

Detailed Status

unknown5
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (14.3%)
N/A6 (85.7%)

Trials by Status

terminated114%
active_not_recruiting114%
unknown571%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
OTHER
Total Trials
7